Back to top

H.C. Wainwright Sticks to Its Buy Rating for Praxis Precision Medicines (PRAX)

In a report released today, Douglas Tsao from H.C. Wainwright reiterated a Buy rating on Praxis Precision Medicines, with a price target of $1,201....

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Praxis Precision Medicines, Inc. (PRAX)